ACRE Ares Commercial Real Estate Corp
- 6.885
- -0.115-1.64%
Ares Commercial Real Estate Corp News
Ares Commercial Real Estate Corporation Schedules Earnings Release and Conference Call for the First Quarter Ended March 31, 2024
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will report earnings for the first quarter ended March 31, 2024 on Thursday, Ma
Ares Commercial Real Est Price Target Cut to $7.50/Share From $8.00 by Keefe, Bruyette & Woods
Ares Commercial Real Est Price Target Cut to $7.50/Share From $8.00 by Keefe, Bruyette & Woods
Ares Commercial Real Est Is Maintained at Neutral by JP Morgan
Ares Commercial Real Est Is Maintained at Neutral by JP Morgan
JP Morgan Maintains Neutral on Ares Comml Real Est, Lowers Price Target to $7
JP Morgan analyst Richard Shane maintains Ares Comml Real Est with a Neutral and lowers the price target from $8 to $7.
Komo: Maintaining the Ares Comml Real Est (ACRE.US) rating, adjusted from neutral to neutral, and adjusted the target price from $8.00 to $7.00.
Komo: Maintaining the Ares Comml Real Est (ACRE.US) rating, adjusted from neutral to neutral, and adjusted the target price from $8.00 to $7.00.
Insiders Buying General American Investors Company And 2 Other Stocks
Although U.S. stocks closed mixed on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the s
Ares Commercial Real Estate Corp(ACRE.US) Officer Buys US$50,266.42 in Common Stock
$Ares Commercial Real Estate Corp(ACRE.US)$ Officer Donohoe Bryan Patrick purchased 3,509 shares of Common Stock on Mar 10, 2020 at an average price of $14.325 for a total value of $50,266.42.Source:
Watch Out - These 5 REITs Could Be Yield Traps
Ares Commercial Real Est Is Maintained at Neutral by UBS
Ares Commercial Real Est Is Maintained at Neutral by UBS
Ares Commercial Real Est Price Target Cut to $8.00/Share From $10.50 by UBS
Ares Commercial Real Est Price Target Cut to $8.00/Share From $10.50 by UBS
UBS Adjusts Ares Commercial Real Estate Price Target to $8 From $10.50, Maintains Neutral Rating
Ares Commercial Real Estate (ACRE) has an average rating of Hold and price targets ranging from $7 to $8, according to analysts polled by Capital IQ. Price: 7.57, Change: +0.02, Percent Change: +0.26
Ares Commercial Real Estate (NYSE:ACRE) Shareholders Have Endured a 10% Loss From Investing in the Stock Five Years Ago
Downgrades Flood In For Commercial Real Estate Stocks: Analysts Warn Of 'Rocky Road Ahead'
Bank of America has downgraded six players in the Commercial Real Estate (CRE) mortgage REIT sector, citing interest rate headwinds and weakening fundamentals that spell a "rocky road ahead" for the i
Ares Commercial, TPG RE Finance, BrightSpire Cut at BofA on CRE Headwinds
Ares Commercial Real Est Price Target Cut to $7.00/Share From $11.00 by B of A Securities
Ares Commercial Real Est Price Target Cut to $7.00/Share From $11.00 by B of A Securities
B of A Securities Downgrades Ares Comml Real Est to Underperform, Lowers Price Target to $7
B of A Securities analyst Eric Dray downgrades Ares Comml Real Est from Buy to Underperform and lowers the price target from $11 to $7.
Wall Street's Most Accurate Analysts Say Hold These 3 Financial Stocks With Over 12% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a hig
Ares Commercial Real Est Is Maintained at Market Perform by Keefe, Bruyette & Woods
Ares Commercial Real Est Is Maintained at Market Perform by Keefe, Bruyette & Woods
Keefe, Bruyette & Woods Maintains Market Perform on Ares Comml Real Est, Lowers Price Target to $8
Keefe, Bruyette & Woods analyst Jade Rahmani maintains Ares Comml Real Est with a Market Perform and lowers the price target from $10.25 to $8.
Ares Commercial Real Est Is Maintained at Neutral by JP Morgan
Ares Commercial Real Est Is Maintained at Neutral by JP Morgan
Analysis
Price Target
No Data
